Nuheara Completes clinical trial
- Nuheara (NUH) completes clinical trial, conducted by the National Acoustics Laboratory (NAL), with all participants data being collected
- NAL is expected to publish the final clinical trial report by the end of this month
- The company says this is an important milestone for US FDA 510(K) submission and regulatory clearance
- The company believes this step will move it closer to entering the US hearing aid market, in line with its expansion plans into global medical devices
- Managing Director and CEO Justin Miller is pleased with the company’s progress
- Shares are trading flat today at 1.6 cents each
